Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice
暂无分享,去创建一个
Michael Berk | Ashley I. Bush | David L. Copolov | M. Berk | A. Bush | D. Copolov | O. Dean | M. Buuse | Olivia Dean | Maarten van den Buuse
[1] O. Pastoris,et al. Age‐related acute depletion of cerebral glutathione by peroxidative stress , 1991, Journal of neuroscience research.
[2] M. Cuénod,et al. N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial , 2008, Biological Psychiatry.
[3] G. Koob,et al. Genetic Differences in Response to Novelty and Spatial Memory Using a Two-Trial Recognition Task in Mice , 2000, Neurobiology of Learning and Memory.
[4] S. Mukherjee,et al. Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.
[5] D. Butterfield,et al. Effect of 2-cyclohexene-1-one-induced glutathione diminution on ischemia/reperfusion-induced alterations in the physical state of brain synaptosomal membrane proteins and lipids , 1997, Neuroscience.
[6] S. Manabe,et al. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine. , 2003, The Journal of toxicological sciences.
[7] S. Oja,et al. Modulation of glutamate receptor functions by glutathione , 2000, Neurochemistry International.
[8] P Boesiger,et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo , 2000, The European journal of neuroscience.
[9] P. Sonsalla. The role of N-methyl-D-aspartate receptors in dopaminergic neuropathology produced by the amphetamines. , 1995, Drug and alcohol dependence.
[10] M. Berk,et al. N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial , 2008, Biological Psychiatry.
[11] Jeffrey K. Yao,et al. Oxidative Damage and Schizophrenia , 2001, CNS drugs.
[12] M. Altschule,et al. Effect of injections of placebos on blood glutathione level and eosinophil counts in chronic schizophrenia. , 1960, Comprehensive psychiatry.
[13] W. Almaguer-Melian,et al. Behavioral and biochemical effects of glutathione depletion in the rat brain , 2001, Brain Research Bulletin.
[14] Yuan-Ye Ma,et al. Improved spatial recognition memory in mice lacking adenosine A2A receptors , 2006, Experimental Neurology.
[15] M. Le Moal,et al. A two-trial memory task with automated recording: study in young and aged rats , 1992, Brain Research.
[16] M. Berk,et al. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. , 2008, The international journal of neuropsychopharmacology.
[17] B. Frey,et al. Changes in Antioxidant Defense Enzymes after d-amphetamine Exposure: Implications as an Animal Model of Mania , 2006, Neurochemical Research.
[18] T. Hastings,et al. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine , 2000, Neuroscience.
[19] M. Le Moal,et al. Extension of a New Two-Trial Memory Task in the Rat: Influence of Environmental Context on Recognition Processes , 1997, Neurobiology of Learning and Memory.
[20] R. Schiestl,et al. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice. , 2006, Carcinogenesis.
[21] E. Pileblad,et al. Intracerebroventricular Administration of l‐Buthionine Sulfoximine: A Method for Depleting Brain Glutathione , 1989, Journal of neurochemistry.
[22] August G. Wang,et al. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. , 2006, American journal of human genetics.
[23] G. Cerniglia,et al. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. , 1990, Analytical biochemistry.
[24] R. Sandhir,et al. Carbofuran-induced neurochemical and neurobehavioral alterations in rats: attenuation by N-acetylcysteine , 2006, Experimental Brain Research.
[25] E. Pileblad,et al. Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-one. , 1990, Life sciences.
[26] J. Franco,et al. Differential susceptibility following β-amyloid peptide-(1–40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response , 2007, Behavioural Brain Research.
[27] Y. Tochino,et al. Methods for depleting brain glutathione. , 1989, Life sciences.
[28] F. Holsboer,et al. γ‐Glutamylglutamine and Taurine Concentrations Are Decreased in the Cerebrospinal Fluid of Drug‐Naive Patients with Schizophrenic Disorders , 1995, Journal of neurochemistry.
[29] M. Cuénod,et al. Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia , 2004, Neurobiology of Disease.
[30] M. Cuénod,et al. An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development , 2004, Neuroscience.
[31] G. Réus,et al. Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[32] Wendy K. Adams,et al. Serotonin depletion in the dorsal and ventral hippocampus: Effects on locomotor hyperactivity, prepulse inhibition and learning and memory , 2008, Neuropharmacology.
[33] Ravinder Reddy,et al. Altered Glutathione Redox State in Schizophrenia , 2005, Disease markers.
[34] P. Mitchell,et al. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. , 2007, Bipolar disorders.
[35] I. Ferrier,et al. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. , 2006, Bipolar disorders.
[36] Benicio N Frey,et al. Oxidative stress markers in bipolar disorder: a meta-analysis. , 2008, Journal of affective disorders.
[37] H. Wedner,et al. Inhibition of human polymorphonuclear leukocyte function by 2-cyclohexene-1-one. A role for glutathione in cell activation. , 1981, The Journal of clinical investigation.
[38] D. D. Hoff,et al. Effect of inhibition of γ-glutamyltranspeptidase by AT-125 (Acivicin) on glutathione and cysteine levels in rat brain and plasma , 2004, Investigational New Drugs.
[39] S. Oja,et al. Release of [3H]GABA evoked by glutamate agonists from hippocampal slices: effects of dithiothreitol and glutathione , 1994, Neurochemistry International.
[40] Trevor R. Norman,et al. Behavioural studies of spatial working memory dysfunction in schizophrenia: A quantitative literature review , 2007, Psychiatry Research.
[41] R. Agarwal,et al. Potential Role of Cerebral Glutathione in the Maintenance of Blood-Brain Barrier Integrity in Rat , 1999, Neurochemical Research.
[42] F. Schenk,et al. Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: Relevance to schizophrenia , 2007, Neurobiology of Disease.